Thromboinflammation and the hypercoagulability of COVID-19
- PMID: 32302453
- PMCID: PMC9770920
- DOI: 10.1111/jth.14849
Thromboinflammation and the hypercoagulability of COVID-19
Comment in
-
A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors.Platelets. 2020 Jul 3;31(5):685-690. doi: 10.1080/09537104.2020.1775189. Epub 2020 Jun 19. Platelets. 2020. PMID: 32552307 No abstract available.
-
Role of upfront CT pulmonary angiography at admission in COVID-19 patients.Thromb Res. 2020 Dec;196:138-140. doi: 10.1016/j.thromres.2020.08.037. Epub 2020 Aug 25. Thromb Res. 2020. PMID: 32866826 Free PMC article.
Comment on
-
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.J Thromb Haemost. 2020 Jul;18(7):1747-1751. doi: 10.1111/jth.14854. Epub 2020 May 6. J Thromb Haemost. 2020. PMID: 32302448 Free PMC article.
References
-
- Jackson S.P., Darbousset R., Schoenwaelder S.M. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood. 2019;133:906–918. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources